Citeline Podcasts

In this edition of Device Week, Medtech Insight's Reed Miller chats with Marion Webb about her upcoming Market Intelligence story covering the global arthroscopy and sports medicine products market, based on Informa's new Meddevicetracker report, with a focus on the fast-growing hip arthroscopy market. Reed Miller discusses Biotronik's new BIO-LIBRA study designed to measure sex-specific outcomes in patients with non-ischemic cardiomyopathy treated with implantable cardioverter defibrillators (ICD) and cardiac resynchronization defibrillators (CRT-D).

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Biotronik Starts First ICD Study Designed To Measure Sex-Specific Outcomes

https://medtech.pharmaintelligence.informa.com/MT125074/Biotronik-Starts-First-ICD-Study-Designed-To-Measure-SexSpecific-Outcomes

In this week's Medtech Insight podcast, Sue Darcey and Shawn M. Schmitt discuss what a rash of new “Medicare for All” bills being explored by the US Congress and several 2020 Democratic presidential hopefuls could mean for the medtech and diagnostics industry.

Medtech Insight articles addressing topics discussed in this episode:

• Medtech CEOs Like Stryker's Lobo 'Scared' Of 'Medicare For All' Driving Lower Device Prices, Former CMS Chief Says

In this edition of Device Week, Medtech Insight's Reed Miller chats with Marion Webb about her Start-Up Spotlight feature on Paragonix Technologies, which hopes to replace conventional organ transportation with its newly launched SherpaPak system. Reed Miller discusses the impact of Boston Scientific's entry into the US TAVR market after the US FDA approved its Lotus Edge TAVR system.

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Boston Scientific Becomes Third US TAVR Competitor With Lotus Edge Approval

Transcatheter Systems Set To Dominate Heart Valve Market

Start-Up Spotlight: Paragonix Wants To Put 'More Heart' Into Transporting Organs

Frans van Houten, CEO of Philips, talked about the future of AI and what his company is doing to be a part of it. He spoke with Medtech Insight at the World Medical Innovation Forum.

In this week's Medtech Insight podcast, Shawn M. Schmitt explains why the FDA ordered transvaginal mesh products removed from the US market, and Ferdous Al-Faruque highlights a growing device-shortage issue linked to problems at two US sterilization facilities.

Medtech Insight articles addressing topics discussed in this episode:

• FDA Yanks Transvaginal Mesh From US Market; Boston Sci 'Surprised'; Firms Have 10 Days To Submit Withdraw Plan

• There's A Pediatric Air-Tube Shortage Because A Sterilization Facility Was Shut Down

• Sterilization Facility Shutdowns Could Spell Medical Device Shortage; FDA Urges Firms To Assess 'Downstream Impacts'

The associate director for digital health talked with Medtech Insight at the World Medical Innovation Forum about international interest in the agency’s precertification pilot program and what is needed to get a new draft guidance on artificial intelligence.

Tags: bakul patel, medical devices, artificial intelligence, pre-cert, digital health, AI, guidance, FDA, world medical innovation forum, WMIF19

In this edition of Device Week, Catherine Longworth reports on eye-care giant Alcon's $28bn spin-off from Novartis. Marion Webb reviews her interview with executives from EOS imaging SA, a developer of imaging medical devices for orthopedics.

Medtech Insight articles addressing topics discussed in this episode:

All 'Bye' Itself: Alcon Spins Out From Novartis In $25Bn Stock Listing

https://bit.ly/2G4qLhX

Adios To Alcon In April As Novartis Confirms Spin-Off Date

https://bit.ly/2Z1xbXA

The Many Layers Of EOS Imaging – Surgical Planning, Low-Dose Imaging, 3D Services

https://bit.ly/2Gf8lwd

In this week’s podcast, Medtech Insight journalists Shawn M. Schmitt, Ferdous Al-Faruque and Elizabeth Orr discuss a recent flurry of guidance document news from US FDA on facility inspections, artificial intelligence and anthrax detection devices.

Medtech Insight articles addressing topics discussed in this episode:

• With Fresh Guidance, US FDA Aims For Consistency In Device Facility Inspections (https://protect-us.mimecast.com/s/fbN6CQWNOwhkRVZoLsPtuEU?domain=medtech.pharmaintelligence.informa.com)

• Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming (https://protect-us.mimecast.com/s/BJD-CR6MLxfvOYZ5XTPiIw3?domain=medtech.pharmaintelligence.informa.com)

• After Years Of Waiting, FDA Classifies Anthrax Detection Devices As Class II (https://protect-us.mimecast.com/s/cBW0CVO5NBcxZBQg8sJEbEK?domain=medtech.pharmaintelligence.informa.com)

In this week's podcast, Medtech Insight's Catherine Longworth discusses UK Oxfordshire's plans to create a regional 'digital-health' hub. And Marion Webb talks about meeting with leaders from Zimmer Biomet and DePuy Synthes to discuss robotic systems and other solutions presented at the recent American Academy of Orthopedics Surgeons' conference in Las Vegas.

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Zimmer Biomet's ROSA One Spine System Wins FDA Nod; Other Solutions Presented At AAOS 2019

AAOS Exec Chat: An Insider Look Into DePuy Synthes' Anterior Approach

AAOS Results Recap: Stryker’s Knee-Surgery Robot And Miach’s New ACL Scaffold

AAOS 2019: OSSO VR Develops VR Training Tool For Smith & Nephew's NAVIO Robot, And More On Orthorobotics

UK Champions Oxfordshire As Next Global Digital Health Hub

What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers

In Vivo discusses ways to enhance the visibility of the market access function in biopharma with two leaders of a 20-company initiative to promote best practices in the field: Indranil Bagchi, Senior Vice-President, Global Value and Access, Novartis Oncology; and Srikant Vaidyanathan, Senior Partner and Managing Director, the Boston Consulting Group.